Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.8K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

579
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
579
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.2K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.2K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

6.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.0K
Protein Networks02:26

Protein Networks

4.1K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

9.3K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
9.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Learning from heterogeneous structural MRI via collaborative domain adaptation for late-Life depression assessment.

Neural networks : the official journal of the International Neural Network Society·2026
Same author

Unbiased clustering of acute-on-chronic liver failure patients using machine learning in a real-world ICU cohort.

Nature communications·2026
Same author

Andrographolide inhibits the upregulation of SLC19A3 to block the adipogenic differentiation of adipose-derived stem cells.

iScience·2026
Same author

Predicting isocitrate dehydrogenase status in glioma using hierarchical attention-based deep 3D multiple instance learning.

Frontiers in oncology·2026
Same author

Hyperbolic Kernel Graph Neural Networks for Neurocognitive Decline Analysis From Multimodal Brain Imaging.

IEEE transactions on pattern analysis and machine intelligence·2025
Same author

DSA-DeepFM: a dual-stage attention-enhanced DeepFM model for predicting anticancer synergistic drug combinations.

Bioinformatics advances·2025

相关实验视频

Updated: Sep 15, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K

高同步 (HIG-Syn):一个超图和交互意识的多粒度网络,用于预测协同作用的药物组合.

Yuexi Gu1, Jian Zu1, Yongheng Sun1

  • 1School of Mathematics and Statistics, Xi'an Jiaotong University, Xi'an, Shaanxi 710049, People's Republic of China.

Bioinformatics (Oxford, England)
|July 15, 2025
PubMed
概括

我们开发了HIG-Syn,这是一种用于预测协同药物组合的新型深度学习模型. 这种模型提高了准确性和生物相关性,显示了药物发现的实际潜力.

更多相关视频

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.0K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.3K

相关实验视频

Last Updated: Sep 15, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.0K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.3K

科学领域:

  • 计算生物学 计算生物学
  • 药理学 药理学是指药理学的学科.
  • 人工智能的人工智能

背景情况:

  • 药物组合可提高疗效,降低毒性.
  • 来自选技术的大型数据集使深度学习能够用于协同预测.
  • 目前的方法缺乏准确性和生物解释性.

研究的目的:

  • 开发一个更准确和生物可解释的深度学习模型来预测药物组合协同作用.
  • 提高计算方法在药物发现中的实际应用.

主要方法:

  • 提出了HIG-Syn (超图和交互意识的多粒度网络) 模型.
  • 集成的粗粒度 (全球特征的超图) 和细粒度 (生物过程的交互意识注意力) 模块.
  • 建模了亚结构-亚结构和亚结构-细胞线的相互作用.

主要成果:

  • 在DrugComb和GDSC2数据集上,HIG-Syn的表现优于最先进的模型.
  • 预测了12种新的协同作用药物组合.
  • 12个预测组合中的5个得到了现有文献的支持,证明了实际的潜力.

结论:

  • HIG-Syn为药物协同作用预测提供了更高的准确性和生物洞察力.
  • 该模型显示了在临床前研究中识别有效和安全的药物组合的巨大潜力.
  • 预测组合的进一步验证是合理的.